AbbVie Targets Dr. Reddy's In Testosterone Gel Patent Suit
An AbbVie Inc. subsidiary on Thursday sued Dr. Reddy's Laboratories Ltd. in Delaware federal court for allegedly infringing 11 patents related to its testosterone gel AndroGel, the second patent suit to...To view the full article, register now.
Already a subscriber? Click here to view full article